Cell Surface Marker Detection Market To Reach 9.12 Billion By 2030

Cell Surface Marker Detection Market Growth & Trends

The global cell surface marker detection market is expected to reach USD 9.12 billion by 2030, expanding at a CAGR of 8.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders. 

Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years. 

Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period. 

 Request a free sample copy or view report summary: Cell Surface Marker Detection Market Report

Cell Surface Marker Detection Market Report Highlights

• The reagents & kits segment dominated the market with a revenue share of 63.3% in 2023. The consumables’ essential role in various detection techniques, including flow cytometry, immunohistochemistry (IHC), and Western blotting primarily drive this dominance.

• The disease diagnosis & identification segment dominated the market with a revenue share of 50.6% in 2023. The increasing prevalence of chronic diseases such as cancer and autoimmune disorders necessitate precise and early diagnosis.

• North America cell surface marker detection market dominated the global market with a revenue share of 39.0% in 2023.

Cell Surface Marker Detection Market Segmentation

Grand View Research has segmented the global cell surface marker detection market on the basis of product, application, and region:

Cell Surface Marker Detection Product Outlook (Revenue, USD Million, 2018 - 2030)

• Flow Cytometry

• Hematology Analyzers

• Reagents & Kits

Cell Surface Marker Detection Application Outlook (Revenue in USD Million, 2018 - 2030)

• Disease Diagnosis & Identification

• Research & Drug Discovery

• Others

Cell Surface Marker Detection Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America 

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • Italy

  • France

  • Spain

  • Norway

  • Sweden

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

    Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Cell Surface Marker Detection Market

• Abbott Laboratories

• Danaher Corporation (Beckman Coulter Inc.)

• Becton, Dickinson and Company

• Bio Rad Laboratories Inc.

• F. Hoffmann-La Roche Ltd

• Diasorin SpA (Luminex Corporation)

• Nihon Kohden Corporation

• Qiagen NV

• Siemens Healthineers

• Thermo Fisher Scientific Inc.